Clinical trial
Drug Use Investigation of Zevalin
NCT01448928 is registered in ClinicalTrials.gov with Spectrum Pharmaceuticals, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Use Investigation of Zevalin
- Lead sponsor
- Spectrum Pharmaceuticals, Inc
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- January 31, 2018
- Enrollment
- 400 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-hodgkin's lymphoma (nhl)